Colchicine has been proposed as a treatment for amyloidosis in animals. It has been used in man to prevent amyloidosis in Familial Mediterranean Fever. It apparently blocks the synthesis and secretion of serum amyloid A (an acute -phase reactant protein) by the liver thereby preventing the formation of amyloid-enhancing factor and preventing amyloid deposition. To be effective it must be given early in the course of the disease and it will be ineffective once kidney failure has occurred.
Effects of colchicine:
Colchicine should be used with caution in geriatric or debilitated animals. It should be used in during pregnancy only when its potential benefits outweigh its risks. Colchicine can cause nausea, vomiting and diarrhea in dogs. It may also cause abdominal pain and loss of appetite. Prolonged administration has caused bone marrow depression in people. Concurrent use with non-steroidal anti-inflammatory agents is not recommended.
I use 0.6mg. (1 tablet) twice a day in Shar-Pei with FSF, littermates with FSF or in lines with amyloidosis. If problems develop on colchicines therapy I stop the drug for a few days and then reinstitute therapy using a once a day dose or use half the dose twice a day. Once dogs become acclimated to the drug I try going with the full dose. Some Shar-Pei do not tolerate colchicine and can't be on the drug. Also colchicine is used as a potential preventive for amyloidosis. It may or may not have an effect on the frequency or severity of the fever episodes.